<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31439839</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>31</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Aug</Month><Day>22</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Sp1-regulated expression of p11 contributes to motor neuron degeneration by membrane insertion of TASK1.</ArticleTitle><Pagination><StartPage>3784</StartPage><MedlinePgn>3784</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">3784</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-019-11637-4</ELocationID><Abstract><AbstractText>Disruption in membrane excitability contributes to malfunction and differential vulnerability of specific neuronal subpopulations in a number of neurological diseases. The adaptor protein p11, and background potassium channel TASK1, have overlapping distributions in the CNS. Here, we report that the transcription factor Sp1 controls p11 expression, which impacts on excitability by hampering functional expression of TASK1. In the SOD1-G93A mouse model of ALS, Sp1-p11-TASK1 dysregulation contributes to increased excitability and vulnerability of motor neurons. Interference with either Sp1 or p11 is neuroprotective, delaying neuron loss and prolonging lifespan in this model. Nitrosative stress, a potential factor in human neurodegeneration, stimulated Sp1 expression and human p11 promoter activity, at least in part, through a Sp1-binding site. Disruption of Sp1 or p11 also has neuroprotective effects in a traumatic model of motor neuron degeneration. Together our work suggests the Sp1-p11-TASK1 pathway is a potential target for treatment of degeneration of motor neurons.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Garc&#xed;a-Morales</LastName><ForeName>Victoria</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-8964-9935</Identifier><AffiliationInfo><Affiliation>Grupo de Neurodegeneraci&#xf3;n y Neurorreparaci&#xf3;n (GRUNEDERE), &#xc1;rea de Fisiolog&#xed;a, Facultad de Medicina, Universidad de C&#xe1;diz, 11003 C&#xe1;diz, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n e Innovaci&#xf3;n Biom&#xe9;dica de C&#xe1;diz (INiBICA), C&#xe1;diz, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez-Bey</LastName><ForeName>Guillermo</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-3597-0245</Identifier><AffiliationInfo><Affiliation>Grupo de Neurodegeneraci&#xf3;n y Neurorreparaci&#xf3;n (GRUNEDERE), &#xc1;rea de Fisiolog&#xed;a, Facultad de Medicina, Universidad de C&#xe1;diz, 11003 C&#xe1;diz, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf3;mez-P&#xe9;rez</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-8615-7241</Identifier><AffiliationInfo><Affiliation>Grupo de Neurodegeneraci&#xf3;n y Neurorreparaci&#xf3;n (GRUNEDERE), &#xc1;rea de Fisiolog&#xed;a, Facultad de Medicina, Universidad de C&#xe1;diz, 11003 C&#xe1;diz, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dom&#xed;nguez-V&#xed;as</LastName><ForeName>Germ&#xe1;n</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-9546-9148</Identifier><AffiliationInfo><Affiliation>Grupo de Neurodegeneraci&#xf3;n y Neurorreparaci&#xf3;n (GRUNEDERE), &#xc1;rea de Fisiolog&#xed;a, Facultad de Medicina, Universidad de C&#xe1;diz, 11003 C&#xe1;diz, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n e Innovaci&#xf3;n Biom&#xe9;dica de C&#xe1;diz (INiBICA), C&#xe1;diz, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez-Forero</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Grupo de Neurodegeneraci&#xf3;n y Neurorreparaci&#xf3;n (GRUNEDERE), &#xc1;rea de Fisiolog&#xed;a, Facultad de Medicina, Universidad de C&#xe1;diz, 11003 C&#xe1;diz, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n e Innovaci&#xf3;n Biom&#xe9;dica de C&#xe1;diz (INiBICA), C&#xe1;diz, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Portillo</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Grupo de Neurodegeneraci&#xf3;n y Neurorreparaci&#xf3;n (GRUNEDERE), &#xc1;rea de Fisiolog&#xed;a, Facultad de Medicina, Universidad de C&#xe1;diz, 11003 C&#xe1;diz, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n e Innovaci&#xf3;n Biom&#xe9;dica de C&#xe1;diz (INiBICA), C&#xe1;diz, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campos-Caro</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8532-2153</Identifier><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n e Innovaci&#xf3;n Biom&#xe9;dica de C&#xe1;diz (INiBICA), C&#xe1;diz, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unidad de Investigaci&#xf3;n, Hospital Universitario Puerta del Mar, C&#xe1;diz, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gento-Caro</LastName><ForeName>&#xc1;ngela</ForeName><Initials>&#xc1;</Initials><AffiliationInfo><Affiliation>Grupo de Neurodegeneraci&#xf3;n y Neurorreparaci&#xf3;n (GRUNEDERE), &#xc1;rea de Fisiolog&#xed;a, Facultad de Medicina, Universidad de C&#xe1;diz, 11003 C&#xe1;diz, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n e Innovaci&#xf3;n Biom&#xe9;dica de C&#xe1;diz (INiBICA), C&#xe1;diz, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Issaoui</LastName><ForeName>Noura</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Grupo de Neurodegeneraci&#xf3;n y Neurorreparaci&#xf3;n (GRUNEDERE), &#xc1;rea de Fisiolog&#xed;a, Facultad de Medicina, Universidad de C&#xe1;diz, 11003 C&#xe1;diz, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soler</LastName><ForeName>Rosa M</ForeName><Initials>RM</Initials><Identifier Source="ORCID">0000-0003-0528-3102</Identifier><AffiliationInfo><Affiliation>Unitat de Senyalitzaci&#xf3; Neuronal, Dept. Medicina Experimental, Universitat de Lleida-IRBLLEIDA, Lleida, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcera</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Unitat de Senyalitzaci&#xf3; Neuronal, Dept. Medicina Experimental, Universitat de Lleida-IRBLLEIDA, Lleida, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno-L&#xf3;pez</LastName><ForeName>Bernardo</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-2897-6227</Identifier><AffiliationInfo><Affiliation>Grupo de Neurodegeneraci&#xf3;n y Neurorreparaci&#xf3;n (GRUNEDERE), &#xc1;rea de Fisiolog&#xed;a, Facultad de Medicina, Universidad de C&#xe1;diz, 11003 C&#xe1;diz, Spain. bernardo.moreno@uca.es.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n e Innovaci&#xf3;n Biom&#xe9;dica de C&#xe1;diz (INiBICA), C&#xe1;diz, Spain. bernardo.moreno@uca.es.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017306">Annexin A2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D024683">Potassium Channels, Tandem Pore Domain</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009418">S100 Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C428424">S100 calcium binding protein A10</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016329">Sp1 Transcription Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>1HQ3YCN4GS</RegistryNumber><NameOfSubstance UI="C420132">potassium channel subfamily K member 3</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017306" MajorTopicYN="N">Annexin A2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002462" MajorTopicYN="N">Cell Membrane</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055785" MajorTopicYN="N">Gene Knockdown Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008564" MajorTopicYN="N">Membrane Potentials</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009410" MajorTopicYN="N">Nerve Degeneration</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024683" MajorTopicYN="N">Potassium Channels, Tandem Pore Domain</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061251" MajorTopicYN="N">Primary Cell Culture</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011401" MajorTopicYN="N">Promoter Regions, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009418" MajorTopicYN="N">S100 Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016329" MajorTopicYN="N">Sp1 Transcription Factor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31439839</ArticleId><ArticleId IdType="pmc">PMC6706379</ArticleId><ArticleId IdType="doi">10.1038/s41467-019-11637-4</ArticleId><ArticleId IdType="pii">10.1038/s41467-019-11637-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Roselli F, Caroni P. From intrinsic firing properties to selective neuronal vulnerability in neurodegenerative diseases. Neuron. 2015;85:901&#x2013;910. doi: 10.1016/j.neuron.2014.12.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.12.063</ArticleId><ArticleId IdType="pubmed">25741719</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena S, Caroni P. Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration. Neuron. 2011;71:35&#x2013;48. doi: 10.1016/j.neuron.2011.06.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.06.031</ArticleId><ArticleId IdType="pubmed">21745636</ArticleId></ArticleIdList></Reference><Reference><Citation>King AE, Woodhouse A, Kirkcaldie MT, Vickers JC. Excitotoxicity in ALS: overstimulation, or overreaction? Exp. Neurol. 2016;275(Pt. 1):162&#x2013;171. doi: 10.1016/j.expneurol.2015.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.09.019</ArticleId><ArticleId IdType="pubmed">26584004</ArticleId></ArticleIdList></Reference><Reference><Citation>Do-Ha, D., Buskila, Y. &amp; Ooi, L. Impairments in motor neurons, interneurons and astrocytes contribute to hyperexcitability in ALS: underlying mechanisms and paths to therapy. Mol. Neurobiol.55, 1410&#x2013;1418 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28160214</ArticleId></ArticleIdList></Reference><Reference><Citation>Bossy-Wetzel E, Schwarzenbacher R, Lipton SA. Molecular pathways to neurodegeneration. Nat. Med. 2004;10(Suppl.):S2&#x2013;S9. doi: 10.1038/nm1067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1067</ArticleId><ArticleId IdType="pubmed">15272266</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Lopez B, Sunico CR, Gonzalez-Forero D. NO orchestrates the loss of synaptic boutons from adult &#x201c;sick&#x201d; motoneurons: modeling a molecular mechanism. Mol. Neurobiol. 2011;43:41&#x2013;66. doi: 10.1007/s12035-010-8159-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-010-8159-8</ArticleId><ArticleId IdType="pubmed">21190141</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau A, Tymianski M. Glutamate receptors, neurotoxicity and neurodegeneration. Pflug. Arch. 2010;460:525&#x2013;542. doi: 10.1007/s00424-010-0809-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00424-010-0809-1</ArticleId><ArticleId IdType="pubmed">20229265</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu Z, Nakamura T, Lipton SA. Redox reactions induced by nitrosative stress mediate protein misfolding and mitochondrial dysfunction in neurodegenerative diseases. Mol. Neurobiol. 2010;41:55&#x2013;72. doi: 10.1007/s12035-010-8113-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-010-8113-9</ArticleId><ArticleId IdType="pmc">PMC4586261</ArticleId><ArticleId IdType="pubmed">20333559</ArticleId></ArticleIdList></Reference><Reference><Citation>Calabrese V, Bates TE, Stella AM. NO synthase and NO-dependent signal pathways in brain aging and neurodegenerative disorders: the role of oxidant/antioxidant balance. Neurochem. Res. 2000;25:1315&#x2013;1341. doi: 10.1023/A:1007604414773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1007604414773</ArticleId><ArticleId IdType="pubmed">11059804</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Forero D, et al. Inhibition of resting potassium conductances by long-term activation of the NO/cGMP/protein kinase G pathway: a new mechanism regulating neuronal excitability. J. Neurosci. 2007;27:6302&#x2013;6312. doi: 10.1523/JNEUROSCI.1019-07.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1019-07.2007</ArticleId><ArticleId IdType="pmc">PMC6672157</ArticleId><ArticleId IdType="pubmed">17554004</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu YM, Yin HZ, Chiang J, Weiss JH. Ca(2+)-permeable AMPA/kainate and NMDA channels: high rate of Ca2+ influx underlies potent induction of injury. J. Neurosci. 1996;16:5457&#x2013;5465. doi: 10.1523/JNEUROSCI.16-17-05457.1996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.16-17-05457.1996</ArticleId><ArticleId IdType="pmc">PMC6578887</ArticleId><ArticleId IdType="pubmed">8757258</ArticleId></ArticleIdList></Reference><Reference><Citation>Simms BA, Zamponi GW. Neuronal voltage-gated calcium channels: structure, function, and dysfunction. Neuron. 2014;82:24&#x2013;45. doi: 10.1016/j.neuron.2014.03.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.03.016</ArticleId><ArticleId IdType="pubmed">24698266</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer ML, Westbrook GL, Guthrie PB. Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones. Nature. 1984;309:261&#x2013;263. doi: 10.1038/309261a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/309261a0</ArticleId><ArticleId IdType="pubmed">6325946</ArticleId></ArticleIdList></Reference><Reference><Citation>Renigunta V, et al. The retention factor p11 confers an endoplasmic reticulum-localization signal to the potassium channel TASK-1. Traffic. 2006;7:168&#x2013;181. doi: 10.1111/j.1600-0854.2005.00375.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0854.2005.00375.x</ArticleId><ArticleId IdType="pubmed">16420525</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayliss DA, Barrett PQ. Emerging roles for two-pore-domain potassium channels and their potential therapeutic impact. Trends Pharmacol. Sci. 2008;29:566&#x2013;575. doi: 10.1016/j.tips.2008.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2008.07.013</ArticleId><ArticleId IdType="pmc">PMC2777628</ArticleId><ArticleId IdType="pubmed">18823665</ArticleId></ArticleIdList></Reference><Reference><Citation>Bittner S, Budde T, Wiendl H, Meuth SG. From the background to the spotlight: TASK channels in pathological conditions. Brain Pathol. 2010;20:999&#x2013;1009. doi: 10.1111/j.1750-3639.2010.00407.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1750-3639.2010.00407.x</ArticleId><ArticleId IdType="pubmed">20529081</ArticleId></ArticleIdList></Reference><Reference><Citation>Milosevic A, et al. Cell- and region-specific expression of depression-related protein p11 (S100a10) in the brain. J. Comp. Neurol. 2017;525:955&#x2013;975. doi: 10.1002/cne.24113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.24113</ArticleId><ArticleId IdType="pmc">PMC5222728</ArticleId><ArticleId IdType="pubmed">27616678</ArticleId></ArticleIdList></Reference><Reference><Citation>Talley EM, Solorzano G, Lei Q, Kim D, Bayliss DA. Cns distribution of members of the two-pore-domain (KCNK) potassium channel family. J. Neurosci. 2001;21:7491&#x2013;7505. doi: 10.1523/JNEUROSCI.21-19-07491.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.21-19-07491.2001</ArticleId><ArticleId IdType="pmc">PMC6762917</ArticleId><ArticleId IdType="pubmed">11567039</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Forero D, Moreno-Lopez B. Retrograde response in axotomized motoneurons: nitric oxide as a key player in triggering reversion toward a dedifferentiated phenotype. Neuroscience. 2014;283:138&#x2013;165. doi: 10.1016/j.neuroscience.2014.08.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2014.08.021</ArticleId><ArticleId IdType="pubmed">25168733</ArticleId></ArticleIdList></Reference><Reference><Citation>Tymianski M, Charlton MP, Carlen PL, Tator CH. Source specificity of early calcium neurotoxicity in cultured embryonic spinal neurons. J. Neurosci. 1993;13:2085&#x2013;2104. doi: 10.1523/JNEUROSCI.13-05-02085.1993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.13-05-02085.1993</ArticleId><ArticleId IdType="pmc">PMC6576557</ArticleId><ArticleId IdType="pubmed">8097530</ArticleId></ArticleIdList></Reference><Reference><Citation>Randall RD, Thayer SA. Glutamate-induced calcium transient triggers delayed calcium overload and neurotoxicity in rat hippocampal neurons. J. Neurosci. 1992;12:1882&#x2013;1895. doi: 10.1523/JNEUROSCI.12-05-01882.1992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.12-05-01882.1992</ArticleId><ArticleId IdType="pmc">PMC6575874</ArticleId><ArticleId IdType="pubmed">1349638</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg AP, Talley EM, Manger JP, Bayliss DA. Motoneurons express heteromeric TWIK-related acid-sensitive K+ (TASK) channels containing TASK-1 (KCNK3) and TASK-3 (KCNK9) subunits. J. Neurosci. 2004;24:6693&#x2013;6702. doi: 10.1523/JNEUROSCI.1408-04.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1408-04.2004</ArticleId><ArticleId IdType="pmc">PMC6729708</ArticleId><ArticleId IdType="pubmed">15282272</ArticleId></ArticleIdList></Reference><Reference><Citation>Pawliczak R, et al. p11 expression in human bronchial epithelial cells is increased by nitric oxide in a cGMP-dependent pathway involving protein kinase G activation. J. Biol. Chem. 2001;276:44613&#x2013;44621. doi: 10.1074/jbc.M104993200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M104993200</ArticleId><ArticleId IdType="pubmed">11571284</ArticleId></ArticleIdList></Reference><Reference><Citation>Pervin S, Singh R, Chaudhuri G. Nitric oxide-induced cytostasis and cell cycle arrest of a human breast cancer cell line (MDA-MB-231): potential role of cyclin D1. Proc. Natl Acad. Sci. USA. 2001;98:3583&#x2013;3588. doi: 10.1073/pnas.041603998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.041603998</ArticleId><ArticleId IdType="pmc">PMC30696</ArticleId><ArticleId IdType="pubmed">11248121</ArticleId></ArticleIdList></Reference><Reference><Citation>Li CQ, Trudel LJ, Wogan GN. Nitric oxide-induced genotoxicity, mitochondrial damage, and apoptosis in human lymphoblastoid cells expressing wild-type and mutant p53. Proc. Natl Acad. Sci. USA. 2002;99:10364&#x2013;10369. doi: 10.1073/pnas.162356399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.162356399</ArticleId><ArticleId IdType="pmc">PMC124920</ArticleId><ArticleId IdType="pubmed">12136132</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, et al. Inhibition of a background potassium channel by Gq protein alpha-subunits. Proc. Natl Acad. Sci. USA. 2006;103:3422&#x2013;3427. doi: 10.1073/pnas.0507710103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0507710103</ArticleId><ArticleId IdType="pmc">PMC1413874</ArticleId><ArticleId IdType="pubmed">16492788</ArticleId></ArticleIdList></Reference><Reference><Citation>Seyler C, et al. TASK1 (K(2P)3.1) K(+) channel inhibition by endothelin-1 is mediated through Rho kinase-dependent phosphorylation. Br. J. Pharmacol. 2012;165:1467&#x2013;1475. doi: 10.1111/j.1476-5381.2011.01626.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1476-5381.2011.01626.x</ArticleId><ArticleId IdType="pmc">PMC3372730</ArticleId><ArticleId IdType="pubmed">21838752</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauzeau V, Rolli-Derkinderen M, Marionneau C, Loirand G, Pacaud P. RhoA expression is controlled by nitric oxide through cGMP-dependent protein kinase activation. J. Biol. Chem. 2003;278:9472&#x2013;9480. doi: 10.1074/jbc.M212776200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M212776200</ArticleId><ArticleId IdType="pubmed">12524425</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X, et al. Characterization of the human p11 promoter sequence. Gene. 2003;310:133&#x2013;142. doi: 10.1016/S0378-1119(03)00529-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0378-1119(03)00529-8</ArticleId><ArticleId IdType="pubmed">12801640</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Lopez B. Local isoform-specific NOS inhibition: a promising approach to promote motor function recovery after nerve injury. J. Neurosci. Res. 2010;88:1846&#x2013;1857.</Citation><ArticleIdList><ArticleId IdType="pubmed">20143424</ArticleId></ArticleIdList></Reference><Reference><Citation>Misawa H, et al. Reappraisal of VAChT-Cre: Preference in slow motor neurons innervating type I or IIa muscle fibers. Genesis. 2016;54:568&#x2013;572. doi: 10.1002/dvg.22979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dvg.22979</ArticleId><ArticleId IdType="pubmed">27596971</ArticleId></ArticleIdList></Reference><Reference><Citation>Misawa H, et al. VAChT-Cre. Fast and VAChT-Cre.Slow: postnatal expression of Cre recombinase in somatomotor neurons with different onset. Genesis. 2003;37:44&#x2013;50. doi: 10.1002/gene.10224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gene.10224</ArticleId><ArticleId IdType="pubmed">14502577</ArticleId></ArticleIdList></Reference><Reference><Citation>Dengler R, et al. Amyotrophic lateral sclerosis: macro-EMG and twitch forces of single motor units. Muscle Nerve. 1990;13:545&#x2013;550. doi: 10.1002/mus.880130612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880130612</ArticleId><ArticleId IdType="pubmed">2366827</ArticleId></ArticleIdList></Reference><Reference><Citation>Pun S, Santos AF, Saxena S, Xu L, Caroni P. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat. Neurosci. 2006;9:408&#x2013;419. doi: 10.1038/nn1653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1653</ArticleId><ArticleId IdType="pubmed">16474388</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegedus J, Putman CT, Gordon T. Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2007;28:154&#x2013;164. doi: 10.1016/j.nbd.2007.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2007.07.003</ArticleId><ArticleId IdType="pubmed">17766128</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu LS, Cheng WC, Shen CK. Targeted depletion of TDP-43 expression in the spinal cord motor neurons leads to the development of amyotrophic lateral sclerosis-like phenotypes in mice. J. Biol. Chem. 2012;287:27335&#x2013;27344. doi: 10.1074/jbc.M112.359000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.359000</ArticleId><ArticleId IdType="pmc">PMC3431639</ArticleId><ArticleId IdType="pubmed">22718760</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson JM, et al. Conditional rhythmicity of ventral spinal interneurons defined by expression of the Hb9 homeodomain protein. J. Neurosci. 2005;25:5710&#x2013;5719. doi: 10.1523/JNEUROSCI.0274-05.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0274-05.2005</ArticleId><ArticleId IdType="pmc">PMC6724883</ArticleId><ArticleId IdType="pubmed">15958737</ArticleId></ArticleIdList></Reference><Reference><Citation>Caldeira V, Dougherty KJ, Borgius L, Kiehn O. Spinal Hb9::Cre-derived excitatory interneurons contribute to rhythm generation in the mouse. Sci. Rep. 2017;7:41369. doi: 10.1038/srep41369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep41369</ArticleId><ArticleId IdType="pmc">PMC5269678</ArticleId><ArticleId IdType="pubmed">28128321</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva H, Polymenidou M, Cleveland DW. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell. Biol. 2009;187:761&#x2013;772. doi: 10.1083/jcb.200908164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200908164</ArticleId><ArticleId IdType="pmc">PMC2806318</ArticleId><ArticleId IdType="pubmed">19951898</ArticleId></ArticleIdList></Reference><Reference><Citation>Devlin AC, et al. Human iPSC-derived motoneurons harbouring TARDBP or C9ORF72 ALS mutations are dysfunctional despite maintaining viability. Nat. Commun. 2015;6:5999. doi: 10.1038/ncomms6999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms6999</ArticleId><ArticleId IdType="pmc">PMC4338554</ArticleId><ArticleId IdType="pubmed">25580746</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, et al. Changes in the excitability of neocortical neurons in a mouse model of amyotrophic lateral sclerosis are not specific to corticospinal neurons and are modulated by advancing disease. J. Neurosci. 2017;37:9037&#x2013;9053. doi: 10.1523/JNEUROSCI.0811-17.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0811-17.2017</ArticleId><ArticleId IdType="pmc">PMC5597984</ArticleId><ArticleId IdType="pubmed">28821643</ArticleId></ArticleIdList></Reference><Reference><Citation>Leroy, F., Lamotte d&#x2019;Incamps, B., Imhoff-Manuel, R.D. &amp; Zytnicki, D. Early intrinsic hyperexcitability does not contribute to motoneuron degeneration in amyotrophic lateral sclerosis. Elife3, &#xa0;e04046 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4227046</ArticleId><ArticleId IdType="pubmed">25313866</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena S, et al. Neuroprotection through excitability and mTOR required in ALS motoneurons to delay disease and extend survival. Neuron. 2013;80:80&#x2013;96. doi: 10.1016/j.neuron.2013.07.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.027</ArticleId><ArticleId IdType="pubmed">24094105</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunico CR, et al. Reduction in the motoneuron inhibitory/excitatory synaptic ratio in an early-symptomatic mouse model of amyotrophic lateral sclerosis. Brain Pathol. 2011;21:1&#x2013;15. doi: 10.1111/j.1750-3639.2010.00417.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1750-3639.2010.00417.x</ArticleId><ArticleId IdType="pubmed">20653686</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin E, Cazenave W, Cattaert D, Branchereau P. Embryonic alteration of motoneuronal morphology induces hyperexcitability in the mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2013;54:116&#x2013;126. doi: 10.1016/j.nbd.2013.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2013.02.011</ArticleId><ArticleId IdType="pubmed">23466698</ArticleId></ArticleIdList></Reference><Reference><Citation>Pambo-Pambo A, Durand J, Gueritaud JP. Early excitability changes in lumbar motoneurons of transgenic SOD1G85R and SOD1G(93A-Low) mice. J. Neurophysiol. 2009;102:3627&#x2013;3642. doi: 10.1152/jn.00482.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.00482.2009</ArticleId><ArticleId IdType="pubmed">19828728</ArticleId></ArticleIdList></Reference><Reference><Citation>van Zundert B, et al. Neonatal neuronal circuitry shows hyperexcitable disturbance in a mouse model of the adult-onset neurodegenerative disease amyotrophic lateral sclerosis. J. Neurosci. 2008;28:10864&#x2013;10874. doi: 10.1523/JNEUROSCI.1340-08.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1340-08.2008</ArticleId><ArticleId IdType="pmc">PMC3844745</ArticleId><ArticleId IdType="pubmed">18945894</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieri M, et al. Altered excitability of motor neurons in a transgenic mouse model of familial amyotrophic lateral sclerosis. Neurosci. Lett. 2003;351:153&#x2013;156. doi: 10.1016/j.neulet.2003.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2003.07.010</ArticleId><ArticleId IdType="pubmed">14623129</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo JJ, Siddique T, Fu R, Heckman CJ. Increased persistent Na(+) current and its effect on excitability in motoneurones cultured from mutant SOD1 mice. J. Physiol. 2005;563:843&#x2013;854. doi: 10.1113/jphysiol.2004.074138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2004.074138</ArticleId><ArticleId IdType="pmc">PMC1665614</ArticleId><ArticleId IdType="pubmed">15649979</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortuno-Sahagun D, et al. Microarray analysis of rat hippocampus exposed to excitotoxicity: reversal Na(+)/Ca(2+) exchanger NCX3 is overexpressed in glial cells. Hippocampus. 2012;22:128&#x2013;140. doi: 10.1002/hipo.20869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hipo.20869</ArticleId><ArticleId IdType="pubmed">20928830</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Z, et al. Long-term increase of Sp-1 transcription factors in the hippocampus after kainic acid treatment. Brain Res. Mol. Brain Res. 1999;69:144&#x2013;148. doi: 10.1016/S0169-328X(99)00099-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0169-328X(99)00099-6</ArticleId><ArticleId IdType="pubmed">10350646</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuravliova E, Barbakadze T, Narmania N, Ramsden J, Mikeladze D. Inhibition of nitric oxide synthase and farnesyltransferase change the activities of several transcription factors. J. Mol. Neurosci. 2007;31:281&#x2013;287.</Citation><ArticleIdList><ArticleId IdType="pubmed">17726232</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhakshinamoorthy S, et al. Protein/DNA arrays identify nitric oxide-regulated cis-element and trans-factor activities some of which govern neuroblastoma cell viability. Nucleic Acids Res. 2007;35:5439&#x2013;5451. doi: 10.1093/nar/gkm594.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkm594</ArticleId><ArticleId IdType="pmc">PMC2018649</ArticleId><ArticleId IdType="pubmed">17702766</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaman K, Palmer LA, Doctor A, Hunt JF, Gaston B. Concentration-dependent effects of endogenous S-nitrosoglutathione on gene regulation by specificity proteins Sp3 and Sp1. Biochem. J. 2004;380:67&#x2013;74. doi: 10.1042/bj20031687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj20031687</ArticleId><ArticleId IdType="pmc">PMC1224145</ArticleId><ArticleId IdType="pubmed">14766015</ArticleId></ArticleIdList></Reference><Reference><Citation>Green Holly, Zhang Xiaoqun, Tiklova Katarina, Volakakis Nikolaos, Brodin Lovisa, Berg Louise, Greengard Paul, Perlmann Thomas, Svenningsson Per. Alterations of p11 in brain tissue and peripheral blood leukocytes in Parkinson&#x2019;s disease. Proceedings of the National Academy of Sciences. 2017;114(10):2735&#x2013;2740. doi: 10.1073/pnas.1621218114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1621218114</ArticleId><ArticleId IdType="pmc">PMC5347629</ArticleId><ArticleId IdType="pubmed">28137881</ArticleId></ArticleIdList></Reference><Reference><Citation>Mithramycin (mithracin For intravenous use. Clin. Pharmacol. Ther. 1971;12:310&#x2013;313. doi: 10.1002/cpt1971122part1310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt1971122part1310</ArticleId><ArticleId IdType="pubmed">5102975</ArticleId></ArticleIdList></Reference><Reference><Citation>Kofman S, Perlia CP, Economou SG. Mithramycin in the treatment of metastatic Ewing&#x2019;s sarcoma. Cancer. 1973;31:889&#x2013;893. doi: 10.1002/1097-0142(197304)31:4&lt;889::AID-CNCR2820310419&gt;3.0.CO;2-H.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1097-0142(197304)31:4&lt;889::AID-CNCR2820310419&gt;3.0.CO;2-H</ArticleId><ArticleId IdType="pubmed">4267530</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilezikian JP. Management of acute hypercalcemia. N. Engl. J. Med. 1992;326:1196&#x2013;1203. doi: 10.1056/NEJM199204303261806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199204303261806</ArticleId><ArticleId IdType="pubmed">1532633</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunez LE, et al. A novel mithramycin analogue with high antitumor activity and less toxicity generated by combinatorial biosynthesis. J. Med. Chem. 2012;55:5813&#x2013;5825. doi: 10.1021/jm300234t.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm300234t</ArticleId><ArticleId IdType="pmc">PMC3395220</ArticleId><ArticleId IdType="pubmed">22578073</ArticleId></ArticleIdList></Reference><Reference><Citation>Osada N, Kosuge Y, Ishige K, Ito Y. Mithramycin, an agent for developing new therapeutic drugs for neurodegenerative diseases. J. Pharmacol. Sci. 2013;122:251&#x2013;256. doi: 10.1254/jphs.13R02CP.</Citation><ArticleIdList><ArticleId IdType="doi">10.1254/jphs.13R02CP</ArticleId><ArticleId IdType="pubmed">23902990</ArticleId></ArticleIdList></Reference><Reference><Citation>Previdi S, et al. Inhibition of Sp1-dependent transcription and antitumor activity of the new aureolic acid analogues mithramycin SDK and SK in human ovarian cancer xenografts. Gynecol. Oncol. 2010;118:182&#x2013;188. doi: 10.1016/j.ygyno.2010.03.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygyno.2010.03.020</ArticleId><ArticleId IdType="pmc">PMC2900446</ArticleId><ArticleId IdType="pubmed">20452660</ArticleId></ArticleIdList></Reference><Reference><Citation>Lesage F, Lazdunski M. Molecular and functional properties of two-pore-domain potassium channels. Am. J. Physiol. Ren. Physiol. 2000;279:F793&#x2013;F801. doi: 10.1152/ajprenal.2000.279.5.F793.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.2000.279.5.F793</ArticleId><ArticleId IdType="pubmed">11053038</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmer DB, Chaplin J, Baldwin A, Rast M. S100-mediated signal transduction in the nervous system and neurological diseases. Cell Mol. Biol. (Noisy-le.-Gd.) 2005;51:201&#x2013;214.</Citation><ArticleIdList><ArticleId IdType="pubmed">16171556</ArticleId></ArticleIdList></Reference><Reference><Citation>Saris CJ, et al. cDNA sequence and tissue distribution of the mRNA for bovine and murine p11, the S100-related light chain of the protein-tyrosine kinase substrate p36 (calpactin I) J. Biol. Chem. 1987;262:10663&#x2013;10671.</Citation><ArticleIdList><ArticleId IdType="pubmed">3038891</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Morales V, et al. Membrane-derived phospholipids control synaptic neurotransmission and plasticity. PLoS Biol. 2015;13:e1002153. doi: 10.1371/journal.pbio.1002153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1002153</ArticleId><ArticleId IdType="pmc">PMC4440815</ArticleId><ArticleId IdType="pubmed">25996636</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Forero D, et al. Endogenous Rho-kinase signaling maintains synaptic strength by stabilizing the size of the readily releasable pool of synaptic vesicles. J. Neurosci. 2012;32:68&#x2013;84. doi: 10.1523/JNEUROSCI.3215-11.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3215-11.2012</ArticleId><ArticleId IdType="pmc">PMC6621323</ArticleId><ArticleId IdType="pubmed">22219271</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Morales V, Montero F, Moreno-Lopez B. Cannabinoid agonists rearrange synaptic vesicles at excitatory synapses and depress motoneuron activity in vivo. Neuropharmacology. 2015;92:69&#x2013;79. doi: 10.1016/j.neuropharm.2014.12.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2014.12.036</ArticleId><ArticleId IdType="pubmed">25595101</ArticleId></ArticleIdList></Reference><Reference><Citation>Gou-Fabregas M, et al. Specific vulnerability of mouse spinal cord motoneurons to membrane depolarization. J. Neurochem. 2009;110:1842&#x2013;1854. doi: 10.1111/j.1471-4159.2009.06278.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.06278.x</ArticleId><ArticleId IdType="pubmed">19627436</ArticleId></ArticleIdList></Reference><Reference><Citation>Montague K, et al. Endoplasmic reticulum stress in spinal and bulbar muscular atrophy: a potential target for therapy. Brain. 2014;137:1894&#x2013;1906. doi: 10.1093/brain/awu114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu114</ArticleId><ArticleId IdType="pmc">PMC4065020</ArticleId><ArticleId IdType="pubmed">24898351</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B, Wang S, Brenner M, Paton JF, Kasparov S. Enhancement of cell-specific transgene expression from a Tet-Off regulatory system using a transcriptional amplification strategy in the rat brain. J. Gene Med. 2008;10:583&#x2013;592. doi: 10.1002/jgm.1178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jgm.1178</ArticleId><ArticleId IdType="pmc">PMC2962808</ArticleId><ArticleId IdType="pubmed">18324737</ArticleId></ArticleIdList></Reference><Reference><Citation>Doetzlhofer A, et al. Histone deacetylase 1 can repress transcription by binding to Sp1. Mol. Cell. Biol. 1999;19:5504&#x2013;5511. doi: 10.1128/MCB.19.8.5504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.19.8.5504</ArticleId><ArticleId IdType="pmc">PMC84392</ArticleId><ArticleId IdType="pubmed">10409740</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakajima H, et al. A rapid, targeted, neuron-selective, in vivo knockdown following a single intracerebroventricular injection of a novel chemically modified siRNA in the adult rat brain. J. Biotechnol. 2012;157:326&#x2013;333. doi: 10.1016/j.jbiotec.2011.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbiotec.2011.10.003</ArticleId><ArticleId IdType="pubmed">22079868</ArticleId></ArticleIdList></Reference><Reference><Citation>Montero F, et al. Transgenic neuronal nitric oxide synthase expression induces axotomy-like changes in adult motoneurons. J. Physiol. 2010;588:3425&#x2013;3443. doi: 10.1113/jphysiol.2010.195396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2010.195396</ArticleId><ArticleId IdType="pmc">PMC2988509</ArticleId><ArticleId IdType="pubmed">20660560</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>